PRECISION BIOSCIENCES INC — Director's Dealing 2021

Feb 2, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2021-01-29

Reporting Person: JANTZ DEREK (Director, Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-01-29	Common Stock	M	21515	$0.04	Acquired	3913789	Direct
2021-01-29	Common Stock	S	6444	$12.25	Disposed	3907345	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-29	Employee Stock Option (Right to Buy)	$0.04	M	21515	Disposed	2021-05-17	Common Stock (21515)	Direct

Footnotes

F1: All sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover the option exercise price and taxes, and the reporting person retaining all remaining shares.

F2: The option is fully vested and exercisable.